|
Short Course | Day 1 |
Day 2
MONDAY, JUNE 8
RECOMMENDED
PRE-CONFERENCE SHORT COURSE*
2:00 – 5:00 pm
(SC5) COLLABORATING TO ACCELERATE THE ADOPTION OF NOVEL TECHNOLOGIES IN
THE PRECLINICAL R&D PROCESS
How much does the ‘Not Invented Here’ mentality inhibit new technology
assessment/implementation in your organization?
What can be done to lower the barriers for new technology or novel
platform adoption?
Can we simplify the technology evaluation process?
Collaborative projects - Is this the solution?
This course provides you with benchmark data techniques to use
collaboration options to more efficiently adopt novel technologies.
Course Instructors: Ernie Bush, Ph.D., Vice President,
Collaborative Projects, Drug Safety Executive Council
Judith Marquis, Ph.D., Group Vice President, Pharmacology and
Preclinical Development, Genzyme
George McCormick, Ph.D., Vice President, Drug Safety &
Disposition, Cephalon
Jack Reynolds, Ph.D., Chairman, Advisory Board, Drug Safety
Executive Council
*Separate
Registration Required
| Drug
Safety Executive Council |
The Drug Safety Executive Council (DSEC) is a peer-to-peer membership of drug safety leaders with the common objective of advancing the development of better and safer medicines worldwide. Membership in DSEC is limited to leaders representing companies who develop small and large molecule pharmaceuticals only. |
|